The Role of T-lymphocytes and Cytokines in Rheumatoid Arthritis

References

• Zvaifler N J, Firestein G S. Pannus and pannocytes. Arthritis Rheum 1994; 37: 783–9
   PubMed Web of Science ®Google Scholar
• Feldmann M, Brennan F M, Field M, Maini R N. Pathogenesis of rheumatoid arthritis: cellular and cytokine interactions. Rheumatoid Arthritis, J S Smolen, J R Kalden, R N Maini. Springer Verlag, Berlin-Heidelberg 1992; 42–54
   Google Scholar
• Kurosaka M, Ziff M. Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med 1983; 158: 1191–210
   PubMed Web of Science ®Google Scholar
• Firestein G S, Zvaifler N J. How important are T cells in chronic rheumatoid synovitis. Arthritis Rheum 1990; 33: 768–73
   PubMed Web of Science ®Google Scholar
• Haynes B F, Grover B J, Whichard L P, et al. Synovial micro-environment T cell interactions. Human T cells bind to fibroblast-like synovial cells in vitro. Arthritis Rheum 1988; 31: 947–55
   PubMed Web of Science ®Google Scholar
• Panayi G S. The immunopathogenesis of rheumatoid arthritis. Br J Rheumatol 1993; 32(Suppl 1)4–14
   PubMedGoogle Scholar
• Horneff G, Burmester G R, Emmrich F, Kalden J R. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum 1991; 34: 129–37
   PubMed Web of Science ®Google Scholar
• Lubbe P Avd, Dijkmans B AC, Markusse H M, Nässander U, Breedveld F C. Lack of clinical effect of CD4 monoclonal antibody therapy in early rheumatoid arthritis: a placebo controlled trial. Arthritis Rheum 1994; 37: S294
   Google Scholar
• Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Koussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991; 10: 4023–31
   Web of Science ®Google Scholar
• Gregersen P K, Silver J, Winchester R J. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205–13
   PubMed Web of Science ®Google Scholar
• Brown J H, Jardetzky T, Saper M A, Samraoui B, Bjorkman P J, Wiley D C. A hypothetical model of the foreign antigen binding site of class II Histocompatibility molecules. Nature 1988; 332: 845–50
   PubMed Web of Science ®Google Scholar
• Dougados M, Awada H, Amor B. Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. Ann Rheum Dis 1988; 47: 127–33
   PubMed Web of Science ®Google Scholar
• Calabrese L H, Wilke W S, Perkins A D, Tubbs R R. RA complicated by infection with the HIV and the development of Sjogren's syndrome. Arthritis Rheum 1989; 32: 1453–7
   PubMed Web of Science ®Google Scholar
• Holter W, Majdic O, Liszka K, Stockinger H, Knapp W. Kinetics of activation antigen expression by in vitro stimulated human T lymphocytes. Cell Immunol 1985; 90: 322–30
   PubMed Web of Science ®Google Scholar
• Pitzalis C, Kingsley G H, Lanchbury J SS, Murphy J, Panayi G S. Expression of HLA DR, DQ, DP antigens and interleukin 2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: Evidence for ‘frustrated’ rheumatoid arthritis. J Rheumatol 1987; 14: 660–6
   Google Scholar
• Pitzalis C, Kingsley G H, Murphy J, Panayi G S. Abnormal distribution of the helper-inducer and suppressor-inducer T lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol 1987; 45: 252–8
   PubMedGoogle Scholar
• Maurer D, Felzmann T, Holter W, Petera P, Smolen J, Knapp W. Evidence for the presence of activated CD4 T cells with naive phenotype in the peripheral blood of patients with rheumatoid arthritis. Clin Exp Immunol 1992; 87: 429–34
   PubMedGoogle Scholar
• Feldmann M, Brennan F M, Field M, Maini R N. Pathogenesis of rheumatoid arthritis: cellular and cytokine interactions. Rheumatoid arthritis. Recent research advances, J S Smolen, J R Kalden, R N Maini. Springer Verlag, Berlin-Heidelberg-New York 1992; 41–54
   Google Scholar
• Steiner G, Witzmann G, Studnicka-Benke A, Höller E, Partsch G, Smolen J. Cytokines in sera and synovial fluids from patients with inflammatory arthritides. Clin Rheumatol 1992; 11: 141
   Google Scholar
• Firestein G S, Zvaifler N J. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that y-interferon is not the primary mactophage activating factor. Arthritis Rheum 1987; 30: 864–71
   PubMed Web of Science ®Google Scholar
• Kunaver M, Steiner G, Gal A, Wessely Zenz M. P, Smolen J. Immunohistochemical localization of IL6, TNFa, IL2 and IFN-y in rheumatoid arthritis synovial membrane. Clin Rheumatol 1993; 12: 121
   Google Scholar
• Steiner G, Tohidast-Akrad M, Kunaver M, Gal A, Smolen J. Production of cytokines by T cells in RA synovial membranes. Clin Rheumatol 1995; 14: 236
   Google Scholar
• Simon A K, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91: 8562–6
   PubMed Web of Science ®Google Scholar
• Chomarat P, Kjeldsen-Kragh J, Quayle A J, Natvig J B, Miossec P. Different cytokine production profiles of gamma delta T cell clones: relation to inflammatory arthritis. Eur J Immunol 1994; 24: 2087–91
   PubMed Web of Science ®Google Scholar
• Katsikis P D, Chu C Q, Brennan F M, Maini R N, Feldmann M. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J Exp Med 1994; 179: 1517–27
   PubMed Web of Science ®Google Scholar
• Andrews H J, Bunning R AD, Plumpton T A, Clark I M, Russel R GG, Cawston T E. Inhibition of interleukin-1-induced colla-genase production in human articular chondrocytes in vitro by recombinant human interferon-gamma. Arthritis Rheum 1990; 33: 1733–8
   PubMedGoogle Scholar
• Machold K P, Neumann K, Smolen J S. Rcombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study. Ann Rheum Dis 1992; 51: 1039–43
   PubMedGoogle Scholar
• Lemmel E M, Gaus W, Hofschneider P H. Multicenter double-blind trial of interferon-gamma versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1991; 34: 1621–2
   PubMedGoogle Scholar
• Bowness P, Bell J., T cell receptors and rheumatmple of Finnish farmers (n=11.368) with a postal questionnaire in 1979 and in another representative sample (n = 3237) using a computer-assisted telephone interview in 1992. Both surveys inquired for musculoskeletal symptoms during the previous year. The one-year prevalence of low-back and joint pain had decreased in all sex and age groups. The total prevalence of neck-shoulder pain had decreased slightly, but not significantly in either sex. The changes in the occurrence of musculoskeletal complaints from 1979 to 1992 may be attributed to the farming policy of the 1980's in Finland. This study is in line with earlier studies showing that musculoskeletal morbidity per se has not increased in the past decade. Even the reverse seems true, if morbidity is defined as trends in symptom occurrence
   Google Scholar